cell-therapy

Documents about cell-therapy

• Case Series on Using Bone Marrow Concentrate for Alar Ligament Injuries#856144ClinicalTrials.gov
• Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer#860239ClinicalTrials.gov
• Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma#174871ClinicalTrials.gov
• Cardiac stem cell therapy following myocardial infarction: a systematic review and meta-analysis of randomized controlled trials#190981ARPHA OAI-PMH Endpoint
• A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet#807922ClinicalTrials.gov
• Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)#839992ClinicalTrials.gov
• A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors#847545ClinicalTrials.gov
• Immune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy#482517HAL (France)
• A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer#829718ClinicalTrials.gov
• Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients#862357ClinicalTrials.gov
• KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis#847923ClinicalTrials.gov
• Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer#859942ClinicalTrials.gov
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer#839796ClinicalTrials.gov
• Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical control.#136149PubMed
• Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation#801495ClinicalTrials.gov
• GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy#836993ClinicalTrials.gov
• A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.#839075ClinicalTrials.gov
• Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research#855864ClinicalTrials.gov
• A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma#860448ClinicalTrials.gov
• Real-world costs per life-year of targeted therapy, incidence, lifetime health impact, and medical costs of renal cell carcinoma in Taiwan.#146040NCBI PubMed Central
• Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis#154632ClinicalTrials.gov
• Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)#208367ClinicalTrials.gov
• A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years.#281117NCBI PubMed Central
• Combination therapy with a novel CD2-targeted costimulatory bispecific antibody overcomes limitations of CD3 T cell engager treatment for solid tumors.#285110NCBI PubMed Central
• Mesenchymal stromal cells for progressive multiple sclerosis: current evidence and translational challenges#342176HAL (France)
• Host-state biomarkers and clinical factors for stratification and optimization of cell therapy trials in chronic limb-threatening ischemia: A review.#440733NCBI PubMed Central
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer#628549ClinicalTrials.gov
• Allogenic transplantation therapy of iPS cell-derived dopamine progenitors for Parkinson's disease -Current status of the Kyoto Trial and future perspectives-#785360Kyoto University Research Information Repository
• Tolerance and Effectiveness of Cell Therapy by Autologous Apoptotic Cells in the Treatment of Rheumatoid Arthritis#803899ClinicalTrials.gov
• GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma#827681ClinicalTrials.gov
• Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO)#842415ClinicalTrials.gov
• Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy#843649ClinicalTrials.gov
• BCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMM#847881ClinicalTrials.gov
• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer#855256ClinicalTrials.gov
• Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors#856196ClinicalTrials.gov
• 4SCAR-CD44v6 T Cell Therapy Targeting Cancer#856288ClinicalTrials.gov
• Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial#262149HAL (France)
• A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248#849243ClinicalTrials.gov
• Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer#806043ClinicalTrials.gov
• Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy#253368Dipòsit Digital de la Universitat de Barcelona
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy#827811ClinicalTrials.gov
• Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer#238105ClinicalTrials.gov
• Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas#835362ClinicalTrials.gov
• Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer#831593ClinicalTrials.gov
• Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC#125832ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer#143633ClinicalTrials.gov
• Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy#146472ClinicalTrials.gov
• Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma#160369ClinicalTrials.gov
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes#217171ClinicalTrials.gov
• Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation#279492ClinicalTrials.gov